Role of immune cells in the removal of deleterious senescent cells
Abhijit Kale1, Amit Sharma2, Alexandra Stolzing2,3
1Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945 USA.
Abstract:
Cellular senescence is an essentially irreversible arrest of cell proliferation coupled to a complex senescence-associated secretory phenotype (SASP). The senescence arrest prevents the development of cancer, and the SASP can promote tissue repair. Recent data suggest that the prolonged presence of senescent cells, and especially the SASP, could be deleterious, and their beneficial effects early in life can become maladaptive such that they drive aging phenotypes and pathologies late in life. It is therefore important to develop strategies to eliminate senescent cells. There are currently under development or approved several immune cell-based therapies for cancer, which could be redesigned to target senescent cells. This review focuses on this possible use of immune cells and discusses how current cell-based therapies could be used for senescent cell removal.
Insights
Cellular senescence, a state of irreversible cell cycle arrest, can drive aging. This review explores using immune cell therapies to eliminate these senescent cells and their harmful secretory phenotype.
Area of Science:
- Cellular biology
- Immunology
- Aging research
Background:
- Cellular senescence is a state of irreversible cell cycle arrest.
- Senescence-associated secretory phenotype (SASP) has dual roles in tissue repair and aging.
- Accumulation of senescent cells and SASP contributes to age-related pathologies.
Purpose of the Study:
- To review the potential of immune cell-based therapies for senescent cell removal.
- To discuss the adaptation of existing cancer immunotherapies for targeting senescent cells.
Main Methods:
- Literature review of cellular senescence, SASP, and immune cell therapies.
- Analysis of current cell-based therapeutic strategies for cancer.
- Exploration of mechanisms for targeting senescent cells with immune cells.
Main Results:
- Senescent cells and their SASP can be detrimental in aging.
- Immune cell-based therapies offer a promising strategy for senescent cell clearance.
- Existing cancer immunotherapies may be adaptable for senolytic purposes.
Conclusions:
- Targeting senescent cells with immune therapies is a viable strategy to combat aging phenotypes.
- Repurposing cancer immunotherapies could accelerate the development of senolytic treatments.
- Further research is needed to optimize immune cell-based senolysis.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cell-mediated Immune Responses
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Replicative Cell Senescence
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...


